BD Posts Revenue Growth of 1 Percent for Q4, 6 Percent for FY2010

The firm reported modest growth for its BD Diagnostics and BD Biosciences segments in Q4, despite the "challenging macroeconomic climate," the firm's chairman and CEO said.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories